37 research outputs found

    Executive Function in Pediatric Bipolar Disorder and Attention-Deficit Hyperactivity Disorder: In Search of Distinct Phenotypic Profiles

    Full text link

    Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery.

    Get PDF
    INTRODUCTION: Postoperative morbidity and mortality in older patients with comorbidities undergoing gastrointestinal surgery are a major burden on healthcare systems. Infections after surgery are common in such patients, prolonging hospitalisation and reducing postoperative short-term and long-term survival. Optimal management of perioperative intravenous fluids and inotropic drugs may reduce infection rates and improve outcomes from surgery. Previous small trials of cardiac-output-guided haemodynamic therapy algorithms suggested a modest reduction in postoperative morbidity. A large definitive trial is needed to confirm or refute this and inform widespread clinical practice. METHODS: The Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial is a multicentre, international, parallel group, open, randomised controlled trial. 2502 high-risk patients undergoing major elective gastrointestinal surgery will be randomly allocated in a 1:1 ratio using minimisation to minimally invasive cardiac output monitoring to guide protocolised administration of intravenous fluid combined with low-dose inotrope infusion, or usual care. The trial intervention will be carried out during and for 4 hours after surgery. The primary outcome is postoperative infection of Clavien-Dindo grade II or higher within 30 days of randomisation. Participants and those delivering the intervention will not be blinded to treatment allocation; however, outcome assessors will be blinded when feasible. Participant recruitment started in January 2017 and is scheduled to last 3 years, within 50 hospitals worldwide. ETHICS/DISSEMINATION: The OPTIMISE II trial has been approved by the UK National Research Ethics Service and has been approved by responsible ethics committees in all participating countries. The findings will be disseminated through publication in a widely accessible peer-reviewed scientific journal. TRIAL REGISTRATION NUMBER: ISRCTN39653756.The OPTIMISE II trial is supported by Edwards Lifesciences (Irvine, CA) and the UK National Institute for Health Research through RMP’s NIHR Professorship

    Distributed link clustering for clustered cooperative MIMO

    Full text link
    © 2014 IEEE. In the cooperative multiple-input/multiple-output (MIMO), multiple access point (AP)-user links form a cluster to increase achievable throughput by cooperatively mitigating inter-user interference within the cluster. In this paper, we propose a clustered cooperative MIMO endowing a constraint on the cluster size such that the clustered MIMO can be implemented as a distributed version of downlink multiuser MIMO in existing standards with minimal modifications. New greedy algorithm and coalition formation algorithm are proposed using matching theory for establishing clusters and allocating frequencies. Simulation results shows that the proposed algorithms achieve almost 20% higher throughput than the fixed cell planning scheme, with very low searching complexity

    Low latency integrated point-to-multipoint and e-band point-to-point backhaul for mobile small cells

    Full text link
    Wireless backhaul is one of the main challenges in small cell deployment. Current wireless backhaul systems have one or more limitations on capacity, link distance and supporting line-of-sight (LOS) links. In this paper, we propose a novel two-tier small-cell backhaul architecture which provides a future-proof, powerful, flexible and scalable solution by using aggregation nodes and integrating sub-6GHz point-to-multipoint (P2MP) and point-to-point E-band links. In the bottom tier of the proposed architecture, local small cells are connected to an aggregation node by P2MP and low-cost mega bits per second (Mbps) E-band links; in the top tier, aggregation nodes are inter-connected by LOS giga bits per second (Gbps) E-band links. PHY and higher layer protocols, which integrate the three different links into a comprehensive solution, are introduced. Designs of devices used in the architecture, which are being developed in CSIRO, are provided. Novel techniques that have been developed for achieving low-latency are detailed. Simulation results show that the backhaul latency can be as low as a few microseconds when only E-band backhaul links are involved. © 2014 IEEE
    corecore